Amneal Pharmaceuticals
Developer and manufacturer of generics, injectables, biosimilars, and branded neurology medicines.
$17.54
After-hours close0.00 (0.00%)
At close$17.54(−2.61%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 52.85%168.76M sharesInsiders 4.57%14.60M sharesOther 42.58%135.97M shares
Shares outstanding 319.33M · Float 163.57M · 51.2% free float
Institutions13F, as of Jun 30, 2026
310 holders · 168.76M shares · 48 new positions · 185 increased · 85 reduced · 56 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 26.56M | 8.32% | +2.04M | Aug 7, 2026 |
| TPG GP A, LLC | 12.33M | 3.86% | 0 | Aug 14, 2026 |
| Vanguard Portfolio Management LLC | 12.14M | 3.80% | +812.8K | Aug 13, 2026 |
| Rubric Capital Management LP | 10.17M | 3.18% | −868.9K | Aug 14, 2026 |
| Vanguard Capital Management LLC | 7.71M | 2.41% | +125.1K | Aug 13, 2026 |
| State Street Corp | 7.36M | 2.30% | +562.3K | Aug 7, 2026 |
| Dimensional Fund Advisors LP | 5.79M | 1.81% | +103.7K | Aug 11, 2026 |
| Geode Capital Management, LLC | 5.14M | 1.61% | +593.4K | Aug 12, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Tushar Patel | 17.60% | 61.34M | 13D | Aug 12, 2026 ↗ |
| Patel Tushar Bhikhubhai | 15.70% | 48.58M | 13D | Mar 17, 2025 ↗ |
| Chintu Patel | 9.40% | 32.58M | 13D | Aug 12, 2026 ↗ |
| Chirag Patel | 8.40% | 29.10M | 13D | Aug 12, 2026 ↗ |
| Patel Chintu | 8.20% | 25.91M | 13D | Oct 7, 2025 ↗ |
| BlackRock, Inc. | 7.60% | 24.12M | 13G | Apr 27, 2026 ↗ |
| Patel Chirag K. | 7.10% | 22.18M | 13D | Aug 8, 2025 ↗ |
| Akram Mahesh | 6.56% | 20.56M | 13G | May 14, 2025 ↗ |
| Patel Dipan | 5.40% | 16.90M | 13D | Mar 26, 2026 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Patel Tushar Bhikhubhai | 10 percent owner | 61.34M | 19.21% | Aug 12, 2026 |
| Chintu Patel | director, officer: Co-CEO | 7.77M | 2.43% | Aug 12, 2026 |
| Gautam Patel | director | 1.93M | 0.60% | Aug 12, 2026 |
| Chirag K. Patel | director, officer: President & Co-CEO | 1.39M | 0.44% | Mar 5, 2026 |
| Paul M. Meister | director | 832.8K | 0.26% | May 8, 2026 |
| Tasos Konidaris | officer: Executive Vice President & CFO | 449.4K | 0.14% | Mar 5, 2026 |
| Jeffrey P. George | director | 344.6K | 0.11% | May 8, 2026 |
| Ted C. Nark | director | 325.8K | 0.10% | May 8, 2026 |
| Shlomo Yanai | director | 320.8K | 0.10% | May 8, 2026 |
| Andrew S. Boyer | officer: Executive Vice President | 273.6K | 0.09% | Aug 25, 2026 |
3 ten-percent owners hold 104.46M shares by Form 4 — the 13D/G table above shows those stakes, the figure above counts officers and directors only · 11 people have not refiled in the last 18 months (30.15M shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 13, 2026 | John Kielydirector | Sale | 50,000 | $17.64 | 210,252 |
| Aug 12, 2026 | Jason B. Dalyofficer: EVP, Chief Legal Officer | Sale | 210,000 | $17.40 | 35,171 |
| Aug 11, 2026 | Jason B. Dalyofficer: EVP, Chief Legal Officer | Sale | 6,613 | $17.70 | 245,171 |
| Aug 12, 2026 | Nikita Shahofficer: Executive Vice President | Sale | 146,403 | $17.51 | 253,390 |
| May 11, 2026 | Deborah M. Autordirector | Sale | 34,819 | $12.94 | 93,660 |
| Nov 17, 2025 | Ted C. Narkdirector | Sale | 50,000 | $11.72 | 291,029 |
| Nov 12, 2025 | Nikita Shahofficer: Executive Vice President | Sale | 131,856 | $11.92 | 146,403 |
CongressHouse and Senate disclosures
Not reported.